NL
TEVA icon

NKCFO LLC’s Teva Pharmaceuticals TEVA Stock Holding History

NKCFO LLC’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.54M Sell
75,000
-3,485
-4% -$116K 0.77% 35
2026
Q1 		$2.36M Buy
78,485
+3,485
+5% +$112K 0.7% 38
2025
Q4 		$2.34M Buy
+75,000
New +$1.85M 0.68% 37
2024
Q4 		– Sell
-3,685
Closed -$66K – 133
2024
Q3 		$66K Buy
+3,685
New +$64.5K 0.03% 75

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

NKCFO LLC's TEVA Position: Q2 2026 in Review

NKCFO LLC reduced its Teva Pharmaceuticals (TEVA) stake by 4.4% in Q2 2026, selling an estimated $116K and leaving 75,000 shares worth $2.54M. The position accounts for 0.77% of the portfolio, ranked #35.

NKCFO LLC first reported a position in TEVA in Q3 2024 and has held it in 4 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • NKCFO LLC held 75,000 shares of Teva Pharmaceuticals worth $2.54M as of Q2 2026.
  • NKCFO LLC sold 3,485 Teva Pharmaceuticals shares in Q2 2026, an estimated $116K.
  • Teva Pharmaceuticals made up 0.77% of NKCFO LLC's portfolio in Q2 2026, its #35 holding.
  • NKCFO LLC first reported a position in Teva Pharmaceuticals in Q3 2024 and has held it in 4 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on NKCFO LLC's 13F filing for Q2 2026, filed 13 Aug 2026.